Vanguard Fiduciary Trust
TIL icon

Vanguard Fiduciary Trust’s Instil Bio TIL Stock Holding History

Vanguard Fiduciary Trust’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$175K Buy
22,773
+148
+0.7% +$1.19K ﹤0.01% 3613
2026
Q1 		$186K Buy
+22,625
New +$184K ﹤0.01% 3539

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $140M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Vanguard Fiduciary Trust's TIL Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Instil Bio (TIL) stake by 0.65% in Q2 2026, buying an estimated $1.19K and bringing the position to 22,773 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #3613.

Vanguard Fiduciary Trust first reported a position in TIL in Q1 2026 and has held it in 2 quarters since. The position peaked at $186K in Q1 2026. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • Vanguard Fiduciary Trust held 22,773 shares of Instil Bio worth $175K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 148 Instil Bio shares in Q2 2026, an estimated $1.19K.
  • Instil Bio made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3613 holding.
  • Vanguard Fiduciary Trust first reported a position in Instil Bio in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Instil Bio position peaked at $186K in Q1 2026.
  • 26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.